Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Picoplatin plus best supportive care versus best supportive care alone in refractory or early relapsed small cell lung cancer
2007-000528-42Phase 3Completed
- Sponsor
- Poniard Pharmaceuticals, Inc.
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in small cell lung cancer (SCLC) comparing Picoplatin + best supportive care with Best supportive care alone (2 arms). Primary endpoint: Overall survival. Started Mar 2007; status: completed.
02
Drugs
picoplatin
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on 2007-000528-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000528-42.